Clinical Trial

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Recruiting
View on ClinicalTrials.gov →
Summary
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.
Trial Details
NCT Number NCT07182981
Lead Sponsor Hacettepe University
Conditions Systemic Sclerosis (SSc), Scleroderma, Scleroderma (Limited and Diffuse), Scleroderma, Localized, Swallowing
Enrollment 50 participants
Start Date 2025-08-04
Primary Completion 2027-08 (estimated)
Study Completion 2027-08-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-19